Complete Filing Data
XCHG Ltd reported Stockholders Equity of $29.51 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean XCHG Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Net Income * | -$11.9M | -$8.1M | $1.6M |
| Selling And Marketing Expense | $10.3M | $6.4M | $3.5M |
| Revenue From Contract With Customer Excluding Assessed Tax | $42.2M | $38.5M | $29.4M |
| Research And Development Expense | $12.2M | $4.1M | $2.8M |
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | $0.00 | $0.00 | $0.00 |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $151.1K | $1.0M | $2.6M |
| Operating Income Loss | -$12.0M | -$6.5M | $1.7M |
| Operating Expenses | $33.3M | $24.5M | $9.1M |
| Net Income Loss Available To Common Stockholders | -$13.1M | -$10.5M | $27.6K |
| Interest Expense | $212.7K | $194.5K | $67.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$11.9M | -$8.1M | $1.6M |
| Gross Profit | $21.2M | $17.6M | $10.7M |
| General And Administrative Expense | $10.8M | $14.0M | $2.7M |
| Cost Of Revenue | $21.0M | $20.9M | $18.7M |
| Comprehensive Income Net Of Tax | -$11.8M | -$7.0M | $4.2M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | $151.1K | $1.0M | $2.6M |
| Income Tax Expense Benefit | -$11.6K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Stockholders Equity | $29.5M | -$30.0M | -$28.0M | -$30.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $26.8M | $15.7M | $8.7M | $4.8M |
| Repayments Of Bank Debt | $7.3M | $4.6M | $3.8M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $11.1M | $7.0M | $3.8M | |
| Temporary Equity Accretion To Redemption Value Adjustment | $1.2M | $2.4M | $1.5M | |
| Retained Earnings Accumulated Deficit | -$52.4M | -$40.4M | ||
| Property Plant And Equipment Net | $969.2K | $576.4K | ||
| Prepaid Expense And Other Assets Current | $6.5M | $3.2M | ||
| Other Receivables Net Current | $2.2M | $1.7M | ||
| Other Liabilities Noncurrent | $166.8K | $80.0K | ||
| Operating Lease Right Of Use Asset | $1.7M | $505.4K | ||
| Operating Lease Liability Noncurrent | $1.3M | $172.1K | ||
| Operating Lease Liability Current | $303.9K | $294.0K | ||
| Long Term Investments | $104.3K | $105.9K | ||
| Liabilities Noncurrent | $1.4M | $252.0K | ||
| Liabilities Current | $26.2M | $30.7M | ||
| Liabilities And Stockholders Equity | $57.1M | $41.0M | ||
| Liabilities | $27.6M | $31.0M | ||
| Inventory Net | $7.7M | $6.7M | ||
| Financial Liabilities Fair Value Disclosure | $189.3K | $247.3K | ||
| Contract With Customer Liability Current | $3.2M | $1.3M | ||
| Cash And Cash Equivalents At Carrying Value | $26.8M | $15.7M | ||
| Assets Noncurrent | $2.7M | $1.2M | ||
| Assets Current | $54.4M | $39.7M | ||
| Assets | $57.1M | $41.0M | ||
| Additional Paid In Capital Common Stock | $79.9M | $6.6M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $2.0M | $1.8M | ||
| Accounts Receivable Net Current | $11.2M | $12.5M | ||
| Accounts Payable Current | $7.7M | $5.8M | ||
| Accounts Payable And Other Accrued Liabilities Current | $5.9M | $5.0M | ||
| Temporary Equity Accretion To Redemption Value | $1.2M | $2.4M | $1.5M | |
| Reduction In Carrying Amount Of Right Of Use Assets | $421.2K | $318.4K | $272.1K | |
| Other Liabilities Current | $125.7K | |||
| Inventory Write Down | $43.2K | $155.6K | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Proceeds From Bank Debt | $8.5M | $6.3M | $6.4M |
| Payments To Purchase Property And Equipment And Intangible Assets | $613.7K | $525.9K | $213.7K |
| Payments Of Initial Public Offering Cost | $1.9M | $1.5M | $120.6K |
| Net Cash Provided By Used In Operating Activities | -$7.2M | -$5.6M | $848.7K |
| Net Cash Provided By Used In Investing Activities | -$533.7K | $2.3M | $1.2M |
| Net Cash Provided By Used In Financing Activities | $19.1M | $10.7M | $2.3M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$333.3K | -$411.0K | -$506.6K |
| Proceeds From Collection Of The Loan To A Related Party Of A Shareholder | $56.3K | $2.9M | $1.4M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $4.7M | -$167.3K | $409.9K |
| Increase Decrease In Other Noncurrent Liabilities | $88.5K | $71.9K | -$7.6K |
| Increase Decrease In Operating Lease Liabilities | -$458.3K | -$345.4K | -$269.7K |
| Increase Decrease In Inventories | $1.3M | $663.5K | $3.4M |
| Increase Decrease In Fair Value Of Financial Instruments | $87.8K | $1.5M | $190.6K |
| Increase Decrease In Due From Related Parties | $1.3M | $469.4K | $256.5K |
| Increase Decrease In Contract Liabilities | $2.0M | -$1.5M | $1.2M |
| Increase Decrease In Accrued Liabilities | -$689.1K | $1.6M | $1.5M |
| Increase Decrease In Accounts Receivable | -$668.1K | $5.1M | $3.6M |
| Increase Decrease In Accounts Payable | $2.4M | -$859.6K | $4.1M |
| Depreciation Depletion And Amortization | $232.9K | $202.9K | $138.1K |
| Share Based Compensation | $7.0M | $7.5M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 1.29B | 713.3M | 656.2M |
| Weighted Average Number Of Diluted Shares Outstanding | 1.29B | 713.3M | 656.2M |
| Earnings Per Share Diluted | $-0.01 | ||
| Earnings Per Share Basic | $-0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Short Term Borrowings | $8.8M | $5.6M | |
| Interest Paid Net | $212.7K | $76.9K | $119.3K |
| Interest Income Operating | $157.7K | $100.8K | $200.9K |
| Government Assistance Operating Income | $38.2K | $428.1K | $27.8K |
| Changes In Fair Value Of Financial Instrument | -$87.8K | -$1.5M | -$190.6K |
| Provision For Doubtful Accounts | $127.3K | $185.3K | $322.9K |
| Foreign Currency Transaction Gain Loss Unrealized | -$218.1K | $205.8K | $423.2K |
Most recent annual filing with the SEC: April 23, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.